[{"address1": "1400 Sierra Point Parkway", "address2": "Building C Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 822 5500", "fax": "650 636 9773", "website": "https://www.annexonbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barr\u00e9 syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.", "fullTimeEmployees": 100, "companyOfficers": [{"maxAge": 1, "name": "Mr. Douglas  Love Esq., J.D.", "age": 56, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 980122, "exercisedValue": 0, "unexercisedValue": 516039}, {"maxAge": 1, "name": "Dr. Dean R. Artis Ph.D.", "age": 63, "title": "Chief Scientific Officer & Executive VP", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 797380, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ted  Yednock Ph.D.", "age": 66, "title": "Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 697760, "exercisedValue": 0, "unexercisedValue": 119297}, {"maxAge": 1, "name": "Ms. Jennifer  Lew CPA", "age": 51, "title": "Executive VP, CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 624195, "exercisedValue": 0, "unexercisedValue": 13124}, {"maxAge": 1, "name": "Mr. Michael  Overdorf M.B.A.", "age": 54, "title": "Executive VP & Chief Business Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 580469, "exercisedValue": 0, "unexercisedValue": 13124}, {"maxAge": 1, "name": "Mr. Henk-Andre  Kroon M.D.", "title": "Senior Vice President of Translational Medicine", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jamie  Dananberg M.D.", "age": 66, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shikhar  Agarwal M.B.A.", "title": "Senior VP & Head of Commercial", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sunil  Mehta Pharm.D.", "title": "Senior VP of Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.53, "open": 2.58, "dayLow": 2.55, "dayHigh": 2.66, "regularMarketPreviousClose": 2.53, "regularMarketOpen": 2.58, "regularMarketDayLow": 2.55, "regularMarketDayHigh": 2.66, "payoutRatio": 0.0, "beta": 1.138, "forwardPE": -2.2807016, "volume": 813026, "regularMarketVolume": 811389, "averageVolume": 1353288, "averageVolume10days": 1022700, "averageDailyVolume10Day": 1022700, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 285245984, "fiftyTwoWeekLow": 2.3, "fiftyTwoWeekHigh": 8.4, "fiftyDayAverage": 3.5658, "twoHundredDayAverage": 5.33865, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2200547, "profitMargins": 0.0, "floatShares": 81750277, "sharesOutstanding": 109710000, "sharesShort": 10895296, "sharesShortPriorMonth": 10086385, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.099300005, "heldPercentInsiders": 0.0057599996, "heldPercentInstitutions": 1.0698301, "shortRatio": 9.14, "shortPercentOfFloat": 0.118, "impliedSharesOutstanding": 109710000, "bookValue": 2.68, "priceToBook": 0.9701492, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -138200000, "trailingEps": -1.01, "forwardEps": -1.14, "enterpriseToEbitda": -0.014, "52WeekChange": -0.5866455, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 2.6, "targetHighPrice": 20.0, "targetLowPrice": 9.0, "targetMeanPrice": 13.33333, "targetMedianPrice": 12.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 312016992, "totalCashPerShare": 2.844, "ebitda": -151923008, "totalDebt": 28972000, "quickRatio": 10.226, "currentRatio": 10.372, "debtToEquity": 9.885, "returnOnAssets": -0.29733, "returnOnEquity": -0.50841, "freeCashflow": -62796624, "operatingCashflow": -118006000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Annexon, Inc.", "firstTradeDateMilliseconds": 1595597400000, "postMarketChangePercent": 0.0, "postMarketPrice": 2.6, "postMarketChange": 0.0, "regularMarketChange": 0.06999993, "regularMarketDayRange": "2.55 - 2.66", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1353288, "fiftyTwoWeekLowChange": 0.29999995, "fiftyTwoWeekLowChangePercent": 0.13043477, "fiftyTwoWeekRange": "2.3 - 8.4", "fiftyTwoWeekHighChange": -5.7999997, "fiftyTwoWeekHighChangePercent": -0.6904762, "fiftyTwoWeekChangePercent": -58.664547, "earningsTimestamp": 1741006800, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.01, "epsForward": -1.14, "epsCurrentYear": -1.22847, "priceEpsCurrentYear": -2.116454, "fiftyDayAverageChange": -0.96580005, "fiftyDayAverageChangePercent": -0.27085087, "twoHundredDayAverageChange": -2.7386503, "twoHundredDayAverageChangePercent": -0.5129855, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "shortName": "Annexon, Inc.", "regularMarketChangePercent": 2.7667959, "regularMarketPrice": 2.6, "corporateActions": [], "postMarketTime": 1741985856, "regularMarketTime": 1741982401, "exchange": "NMS", "messageBoardId": "finmb_279883519", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "displayName": "Annexon", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]